Literature DB >> 214791

Infectious murine leukemia virus from DNA of virus-negative AKR mouse embryo cells.

D R Lowy.   

Abstract

DNA from virus-negative AKR mouse embryo cells is infectious for NIH 3T3 cells if the transfected cells are treated with 5-iododeoxyuridine (IdUrd) either before or after addition of the DNA. The virus isolated after transfection of the AKR DNA is an ecotropic murine leukemia virus (MuLV) indistinguishable from endogenous AKR MuLV. The AKR DNA is not infectious in the absence of IdUrd treatment of the recipient cells. DNA from AKR cells treated with IdUrd before DNA isolation is not infectious unless the recipient cells have been treated with IdUrd. Transfected DNA from NIH mouse cells is not infectious even when the recipient cells have been treated with IdUrd. DNA from cells chronically infected with AKR MuLV or Rauscher MuLV is infectious with or without IdUrd treatment of the recipient cells, but the infectivity is not enhanced by IdUrd. The results indicate that the endogenous AKR MuLV DNA genome is potentially infectious. The data are consistent with an IdUrd-sensitive restriction in the recipient NIH 3T3 cells that prevents viral replication from endogenous AKR MuLV DNA but does not prevent viral replication from MuLV DNA of productively infected cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214791      PMCID: PMC393001          DOI: 10.1073/pnas.75.11.5539

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Presence of chicken tumour virus in the sarcoma of the adult rat inoculated after birth with Rous sarcoma tissue.

Authors:  J SVOBODA
Journal:  Nature       Date:  1960-06-18       Impact factor: 49.962

2.  Infectious viral DNA of murine leukemia virus.

Authors:  D Smotkin; A M Gianni; S Rozenblatt; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

3.  Potentiating effect of iododeoxyuridine on MuLV replication in mouse embryo fibroblasts.

Authors:  O Niwa; A Declève; H S Kaplan
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

4.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

5.  Helper-independent transformation by unintegrated Harvey sarcoma virus DNA.

Authors:  D R Lowy; E Rands; E M Scolnick
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

Review 6.  Endogenous type-C RNA viruses of mammalian cells.

Authors:  S A Aaronson; J R Stephenson
Journal:  Biochim Biophys Acta       Date:  1976-12-23

7.  Marker rescue of endogenous cellular genetic information related to the avian leukosis virus gene encoding RNA-directed DNA polymerase.

Authors:  G M Cooper
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

8.  Lack of infectivity of the endogenous avian leukosis virus-related genes in the DNA of uninfected chicken cells.

Authors:  G M Cooper; H M Temin
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

9.  Type C particle-positive and type C particle-negative rat cell lines: characterization of the coding capacity of endogenous sarcoma virus-specific RNA.

Authors:  E M Scolnick; D Williams; J Maryak; W Vass; R J Goldberg; W P Parks
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

10.  Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material.

Authors:  S K Chattopadhyay; W P Rowe; N M Teich; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  11 in total

1.  Retroviral gag gene amber codon suppression is caused by an intrinsic cis-acting component of the viral mRNA.

Authors:  A T Panganiban
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

2.  Carcinogen- and radiation-transformed C3H 10T1/2 cells contain RNAs homologous to the long terminal repeat sequence of a murine leukemia virus.

Authors:  P Kirschmeier; S Gattoni-Celli; D Dina; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells.

Authors:  D R Lowy; E Rands; S K Chattopadhyay; C F Garon; G L Hager
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

4.  Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity.

Authors:  N C Dracopoli; A N Houghton; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Structure of endogenous murine leukemia virus DNA in mouse genomes.

Authors:  S K Chattopadhyay; M R Lander; E Rands; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  DNA-mediated transfer of human melanoma cell surface glycoprotein gp130: identification of transfectants by erythrocyte rosetting.

Authors:  A P Albino; L H Graf; R R Kantor; W McLean; S Silagi; L J Old
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

7.  Genomes of murine leukemia viruses isolated from wild mice.

Authors:  S K Chattopadhyay; A I Oliff; D L Linemeyer; M R Lander; D R Lowy
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

8.  DNAs of two molecularly cloned endogenous ecotropic proviruses are poorly infectious in DNA transfection assays.

Authors:  N G Copeland; H G Bedigian; C Y Thomas; N A Jenkins
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

9.  The transforming function of bovine papillomavirus DNA.

Authors:  Y Nakabayashi; S K Chattopadhyay; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Kinetics of expression of infectious ecotropic, xenotropic, and mink cell focus-forming murine leukemia virus after 5-iododeoxyuridine induction of cells from high- and low-leukemia mouse strains.

Authors:  U R Rapp
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.